Neoadjuvant therapy refers to treatment before surgery and it aims to shrink the breast cancer in size to increase the chance of breast-conserving surgery and to monitor the effect of treatment on the tumour.

In this podcast, Associate Professor Prue Francis, the Chair of the Breast Cancer Trials Scientific Advisory Committee, explains the potential benefits of neoadjuvant therapy and why it's been increasingly used in breast cancer research.

Find out more: www.breastcancertrials.org.au